Eshelman Ventures, LLC — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Innocrin Pharmaceuticals HoldingsApr 2015SEC filingmedium confidence
BiotechDurham, US
Richard Kent(Director)Kristopher Wood(Director)Thomas Laundon(Executive Officer)S. Edward Torres(Director)Steven Weinstein(Director)William Moore(Executive Officer, Director)
Board seatFred Eshelman· per SEC Form D · $28.1M raise · filed Apr 2015
NeoantigenicsFeb 2015SEC filingmedium confidence
BiotechCharlottesville, US
Edward J. Leary(Executive Officer, Promoter)Brian A. Pollok(Executive Officer, Director, Promoter)John C. Herr(Executive Officer, Director, Promoter)
Board seatFred Eshelman· per SEC Form D · $3M raise · filed Feb 2015
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.